• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Wearable Injector Devices Market Insights, Forecast to 2026

report cover
  • 22 June 2020
  • Medical Devices
  • 117 Pages
  • Report Code: 24LS-8625
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Wearable Injector Devices -MARKET ADVISORY SERVICES

Wearable Injector Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Wearable Injector Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Wearable Injector Devices market is segmented into
Disposable
Reusable

Segment by Application, the Wearable Injector Devices market is segmented into
Oncology
Diabetes
Cardiovascular Diseases
Autoimmune Disorder
Infectious Diseases
Others

Regional and Country-level Analysis
The Wearable Injector Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Wearable Injector Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Wearable Injector Devices Market Share Analysis

Wearable Injector Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Wearable Injector Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Wearable Injector Devices business, the date to enter into the Wearable Injector Devices market, Wearable Injector Devices product introduction, recent developments, etc.
The major vendors covered:
SteadyMed Therapeutics, Inc.
UNILIFE CORPORATION
Sensile Medical AGInsulet Corporation
Enable Injections
Becton
West Pharmaceutical Services, Inc.
Ypsomed
Amgen
Buhler Motor GmbH
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
1 Study Coverage
1.1 Wearable Injector Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Wearable Injector Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Wearable Injector Devices Market Size Growth Rate by Type
1.4.2 Disposable
1.4.3 Reusable
1.5 Market by Application
1.5.1 Global Wearable Injector Devices Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Diseases
1.5.5 Autoimmune Disorder
1.5.6 Infectious Diseases
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Wearable Injector Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Wearable Injector Devices Industry
1.6.1.1 Wearable Injector Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Wearable Injector Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Wearable Injector Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Wearable Injector Devices Market Size Estimates and Forecasts
2.1.1 Global Wearable Injector Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Wearable Injector Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Wearable Injector Devices Production Estimates and Forecasts 2015-2026
2.2 Global Wearable Injector Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Wearable Injector Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Wearable Injector Devices Manufacturers Geographical Distribution
2.4 Key Trends for Wearable Injector Devices Markets & Products
2.5 Primary Interviews with Key Wearable Injector Devices Players (Opinion Leaders)

3 Market Size by Manufacturers
3.1 Global Top Wearable Injector Devices Manufacturers by Production Capacity
3.1.1 Global Top Wearable Injector Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Wearable Injector Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Wearable Injector Devices Manufacturers Market Share by Production
3.2 Global Top Wearable Injector Devices Manufacturers by Revenue
3.2.1 Global Top Wearable Injector Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Wearable Injector Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Wearable Injector Devices Revenue in 2019
3.3 Global Wearable Injector Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Wearable Injector Devices Production by Regions
4.1 Global Wearable Injector Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Wearable Injector Devices Regions by Production (2015-2020)
4.1.2 Global Top Wearable Injector Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Wearable Injector Devices Production (2015-2020)
4.2.2 North America Wearable Injector Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Wearable Injector Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Wearable Injector Devices Production (2015-2020)
4.3.2 Europe Wearable Injector Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Wearable Injector Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Wearable Injector Devices Production (2015-2020)
4.4.2 China Wearable Injector Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Wearable Injector Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Wearable Injector Devices Production (2015-2020)
4.5.2 Japan Wearable Injector Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Wearable Injector Devices Import & Export (2015-2020)

5 Wearable Injector Devices Consumption by Region
5.1 Global Top Wearable Injector Devices Regions by Consumption
5.1.1 Global Top Wearable Injector Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Wearable Injector Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Wearable Injector Devices Consumption by Application
5.2.2 North America Wearable Injector Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Wearable Injector Devices Consumption by Application
5.3.2 Europe Wearable Injector Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Wearable Injector Devices Consumption by Application
5.4.2 Asia Pacific Wearable Injector Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Wearable Injector Devices Consumption by Application
5.5.2 Central & South America Wearable Injector Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Wearable Injector Devices Consumption by Application
5.6.2 Middle East and Africa Wearable Injector Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E

6 Market Size by Type (2015-2026)
6.1 Global Wearable Injector Devices Market Size by Type (2015-2020)
6.1.1 Global Wearable Injector Devices Production by Type (2015-2020)
6.1.2 Global Wearable Injector Devices Revenue by Type (2015-2020)
6.1.3 Wearable Injector Devices Price by Type (2015-2020)
6.2 Global Wearable Injector Devices Market Forecast by Type (2021-2026)
6.2.1 Global Wearable Injector Devices Production Forecast by Type (2021-2026)
6.2.2 Global Wearable Injector Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Wearable Injector Devices Price Forecast by Type (2021-2026)
6.3 Global Wearable Injector Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)
7.2.1 Global Wearable Injector Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Wearable Injector Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles
8.1 SteadyMed Therapeutics, Inc.
8.1.1 SteadyMed Therapeutics, Inc. Corporation Information
8.1.2 SteadyMed Therapeutics, Inc. Overview and Its Total Revenue
8.1.3 SteadyMed Therapeutics, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 SteadyMed Therapeutics, Inc. Product Description
8.1.5 SteadyMed Therapeutics, Inc. Recent Development
8.2 UNILIFE CORPORATION
8.2.1 UNILIFE CORPORATION Corporation Information
8.2.2 UNILIFE CORPORATION Overview and Its Total Revenue
8.2.3 UNILIFE CORPORATION Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 UNILIFE CORPORATION Product Description
8.2.5 UNILIFE CORPORATION Recent Development
8.3 Sensile Medical AGInsulet Corporation
8.3.1 Sensile Medical AGInsulet Corporation Corporation Information
8.3.2 Sensile Medical AGInsulet Corporation Overview and Its Total Revenue
8.3.3 Sensile Medical AGInsulet Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Sensile Medical AGInsulet Corporation Product Description
8.3.5 Sensile Medical AGInsulet Corporation Recent Development
8.4 Enable Injections
8.4.1 Enable Injections Corporation Information
8.4.2 Enable Injections Overview and Its Total Revenue
8.4.3 Enable Injections Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Enable Injections Product Description
8.4.5 Enable Injections Recent Development
8.5 Becton
8.5.1 Becton Corporation Information
8.5.2 Becton Overview and Its Total Revenue
8.5.3 Becton Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Becton Product Description
8.5.5 Becton Recent Development
8.6 West Pharmaceutical Services, Inc.
8.6.1 West Pharmaceutical Services, Inc. Corporation Information
8.6.2 West Pharmaceutical Services, Inc. Overview and Its Total Revenue
8.6.3 West Pharmaceutical Services, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 West Pharmaceutical Services, Inc. Product Description
8.6.5 West Pharmaceutical Services, Inc. Recent Development
8.7 Ypsomed
8.7.1 Ypsomed Corporation Information
8.7.2 Ypsomed Overview and Its Total Revenue
8.7.3 Ypsomed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Ypsomed Product Description
8.7.5 Ypsomed Recent Development
8.8 Amgen
8.8.1 Amgen Corporation Information
8.8.2 Amgen Overview and Its Total Revenue
8.8.3 Amgen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Amgen Product Description
8.8.5 Amgen Recent Development
8.9 Buhler Motor GmbH
8.9.1 Buhler Motor GmbH Corporation Information
8.9.2 Buhler Motor GmbH Overview and Its Total Revenue
8.9.3 Buhler Motor GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Buhler Motor GmbH Product Description
8.9.5 Buhler Motor GmbH Recent Development
8.10 F. Hoffmann-La Roche Ltd
8.10.1 F. Hoffmann-La Roche Ltd Corporation Information
8.10.2 F. Hoffmann-La Roche Ltd Overview and Its Total Revenue
8.10.3 F. Hoffmann-La Roche Ltd Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 F. Hoffmann-La Roche Ltd Product Description
8.10.5 F. Hoffmann-La Roche Ltd Recent Development
8.11 Johnson & Johnson Services, Inc.
8.11.1 Johnson & Johnson Services, Inc. Corporation Information
8.11.2 Johnson & Johnson Services, Inc. Overview and Its Total Revenue
8.11.3 Johnson & Johnson Services, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Johnson & Johnson Services, Inc. Product Description
8.11.5 Johnson & Johnson Services, Inc. Recent Development
8.12 CeQur SA.
8.12.1 CeQur SA. Corporation Information
8.12.2 CeQur SA. Overview and Its Total Revenue
8.12.3 CeQur SA. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 CeQur SA. Product Description
8.12.5 CeQur SA. Recent Development

9 Production Forecasts by Regions
9.1 Global Top Wearable Injector Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Wearable Injector Devices Regions Forecast by Production (2021-2026)
9.3 Key Wearable Injector Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan

10 Wearable Injector Devices Consumption Forecast by Region
10.1 Global Wearable Injector Devices Consumption Forecast by Region (2021-2026)
10.2 North America Wearable Injector Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Wearable Injector Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Wearable Injector Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Wearable Injector Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Wearable Injector Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Wearable Injector Devices Sales Channels
11.2.2 Wearable Injector Devices Distributors
11.3 Wearable Injector Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Wearable Injector Devices Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables

Table 1. Wearable Injector Devices Key Market Segments in This Study

Table 2. Ranking of Global Top Wearable Injector Devices Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Wearable Injector Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)

Table 4. Major Manufacturers of Disposable

Table 5. Major Manufacturers of Reusable

Table 6. COVID-19 Impact Global Market: (Four Wearable Injector Devices Market Size Forecast Scenarios)

Table 7. Opportunities and Trends for Wearable Injector Devices Players in the COVID-19 Landscape

Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 9. Key Regions/Countries Measures against Covid-19 Impact

Table 10. Proposal for Wearable Injector Devices Players to Combat Covid-19 Impact

Table 11. Global Wearable Injector Devices Market Size Growth Rate by Application 2020-2026 (K Units)

Table 12. Global Wearable Injector Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Wearable Injector Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wearable Injector Devices as of 2019)

Table 15. Wearable Injector Devices Manufacturing Base Distribution and Headquarters

Table 16. Manufacturers Wearable Injector Devices Product Offered

Table 17. Date of Manufacturers Enter into Wearable Injector Devices Market

Table 18. Key Trends for Wearable Injector Devices Markets & Products

Table 19. Main Points Interviewed from Key Wearable Injector Devices Players

Table 20. Global Wearable Injector Devices Production Capacity by Manufacturers (2015-2020) (K Units)

Table 21. Global Wearable Injector Devices Production Share by Manufacturers (2015-2020)

Table 22. Wearable Injector Devices Revenue by Manufacturers (2015-2020) (Million US$)

Table 23. Wearable Injector Devices Revenue Share by Manufacturers (2015-2020)

Table 24. Wearable Injector Devices Price by Manufacturers 2015-2020 (USD/Unit)

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Wearable Injector Devices Production by Regions (2015-2020) (K Units)

Table 27. Global Wearable Injector Devices Production Market Share by Regions (2015-2020)

Table 28. Global Wearable Injector Devices Revenue by Regions (2015-2020) (US$ Million)

Table 29. Global Wearable Injector Devices Revenue Market Share by Regions (2015-2020)

Table 30. Key Wearable Injector Devices Players in North America

Table 31. Import & Export of Wearable Injector Devices in North America (K Units)

Table 32. Key Wearable Injector Devices Players in Europe

Table 33. Import & Export of Wearable Injector Devices in Europe (K Units)

Table 34. Key Wearable Injector Devices Players in China

Table 35. Import & Export of Wearable Injector Devices in China (K Units)

Table 36. Key Wearable Injector Devices Players in Japan

Table 37. Import & Export of Wearable Injector Devices in Japan (K Units)

Table 38. Global Wearable Injector Devices Consumption by Regions (2015-2020) (K Units)

Table 39. Global Wearable Injector Devices Consumption Market Share by Regions (2015-2020)

Table 40. North America Wearable Injector Devices Consumption by Application (2015-2020) (K Units)

Table 41. North America Wearable Injector Devices Consumption by Countries (2015-2020) (K Units)

Table 42. Europe Wearable Injector Devices Consumption by Application (2015-2020) (K Units)

Table 43. Europe Wearable Injector Devices Consumption by Countries (2015-2020) (K Units)

Table 44. Asia Pacific Wearable Injector Devices Consumption by Application (2015-2020) (K Units)

Table 45. Asia Pacific Wearable Injector Devices Consumption Market Share by Application (2015-2020) (K Units)

Table 46. Asia Pacific Wearable Injector Devices Consumption by Regions (2015-2020) (K Units)

Table 47. Latin America Wearable Injector Devices Consumption by Application (2015-2020) (K Units)

Table 48. Latin America Wearable Injector Devices Consumption by Countries (2015-2020) (K Units)

Table 49. Middle East and Africa Wearable Injector Devices Consumption by Application (2015-2020) (K Units)

Table 50. Middle East and Africa Wearable Injector Devices Consumption by Countries (2015-2020) (K Units)

Table 51. Global Wearable Injector Devices Production by Type (2015-2020) (K Units)

Table 52. Global Wearable Injector Devices Production Share by Type (2015-2020)

Table 53. Global Wearable Injector Devices Revenue by Type (2015-2020) (Million US$)

Table 54. Global Wearable Injector Devices Revenue Share by Type (2015-2020)

Table 55. Wearable Injector Devices Price by Type 2015-2020 (USD/Unit)

Table 56. Global Wearable Injector Devices Consumption by Application (2015-2020) (K Units)

Table 57. Global Wearable Injector Devices Consumption by Application (2015-2020) (K Units)

Table 58. Global Wearable Injector Devices Consumption Share by Application (2015-2020)

Table 59. SteadyMed Therapeutics, Inc. Corporation Information

Table 60. SteadyMed Therapeutics, Inc. Description and Major Businesses

Table 61. SteadyMed Therapeutics, Inc. Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 62. SteadyMed Therapeutics, Inc. Product

Table 63. SteadyMed Therapeutics, Inc. Recent Development

Table 64. UNILIFE CORPORATION Corporation Information

Table 65. UNILIFE CORPORATION Description and Major Businesses

Table 66. UNILIFE CORPORATION Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 67. UNILIFE CORPORATION Product

Table 68. UNILIFE CORPORATION Recent Development

Table 69. Sensile Medical AGInsulet Corporation Corporation Information

Table 70. Sensile Medical AGInsulet Corporation Description and Major Businesses

Table 71. Sensile Medical AGInsulet Corporation Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 72. Sensile Medical AGInsulet Corporation Product

Table 73. Sensile Medical AGInsulet Corporation Recent Development

Table 74. Enable Injections Corporation Information

Table 75. Enable Injections Description and Major Businesses

Table 76. Enable Injections Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 77. Enable Injections Product

Table 78. Enable Injections Recent Development

Table 79. Becton Corporation Information

Table 80. Becton Description and Major Businesses

Table 81. Becton Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 82. Becton Product

Table 83. Becton Recent Development

Table 84. West Pharmaceutical Services, Inc. Corporation Information

Table 85. West Pharmaceutical Services, Inc. Description and Major Businesses

Table 86. West Pharmaceutical Services, Inc. Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 87. West Pharmaceutical Services, Inc. Product

Table 88. West Pharmaceutical Services, Inc. Recent Development

Table 89. Ypsomed Corporation Information

Table 90. Ypsomed Description and Major Businesses

Table 91. Ypsomed Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 92. Ypsomed Product

Table 93. Ypsomed Recent Development

Table 94. Amgen Corporation Information

Table 95. Amgen Description and Major Businesses

Table 96. Amgen Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 97. Amgen Product

Table 98. Amgen Recent Development

Table 99. Buhler Motor GmbH Corporation Information

Table 100. Buhler Motor GmbH Description and Major Businesses

Table 101. Buhler Motor GmbH Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 102. Buhler Motor GmbH Product

Table 103. Buhler Motor GmbH Recent Development

Table 104. F. Hoffmann-La Roche Ltd Corporation Information

Table 105. F. Hoffmann-La Roche Ltd Description and Major Businesses

Table 106. F. Hoffmann-La Roche Ltd Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 107. F. Hoffmann-La Roche Ltd Product

Table 108. F. Hoffmann-La Roche Ltd Recent Development

Table 109. Johnson & Johnson Services, Inc. Corporation Information

Table 110. Johnson & Johnson Services, Inc. Description and Major Businesses

Table 111. Johnson & Johnson Services, Inc. Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 112. Johnson & Johnson Services, Inc. Product

Table 113. Johnson & Johnson Services, Inc. Recent Development

Table 114. CeQur SA. Corporation Information

Table 115. CeQur SA. Description and Major Businesses

Table 116. CeQur SA. Wearable Injector Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 117. CeQur SA. Product

Table 118. CeQur SA. Recent Development

Table 119. Global Wearable Injector Devices Revenue Forecast by Region (2021-2026) (Million US$)

Table 120. Global Wearable Injector Devices Production Forecast by Regions (2021-2026) (K Units)

Table 121. Global Wearable Injector Devices Production Forecast by Type (2021-2026) (K Units)

Table 122. Global Wearable Injector Devices Revenue Forecast by Type (2021-2026) (Million US$)

Table 123. North America Wearable Injector Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 124. Europe Wearable Injector Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 125. Asia Pacific Wearable Injector Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 126. Latin America Wearable Injector Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 127. Middle East and Africa Wearable Injector Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 128. Wearable Injector Devices Distributors List

Table 129. Wearable Injector Devices Customers List

Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 131. Key Challenges

Table 132. Market Risks

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Fifures

Figure 1. Wearable Injector Devices Product Picture

Figure 2. Global Wearable Injector Devices Production Market Share by Type in 2020 & 2026

Figure 3. Disposable Product Picture

Figure 4. Reusable Product Picture

Figure 5. Global Wearable Injector Devices Consumption Market Share by Application in 2020 & 2026

Figure 6. Oncology

Figure 7. Diabetes

Figure 8. Cardiovascular Diseases

Figure 9. Autoimmune Disorder

Figure 10. Infectious Diseases

Figure 11. Others

Figure 12. Wearable Injector Devices Report Years Considered

Figure 13. Global Wearable Injector Devices Revenue 2015-2026 (Million US$)

Figure 14. Global Wearable Injector Devices Production Capacity 2015-2026 (K Units)

Figure 15. Global Wearable Injector Devices Production 2015-2026 (K Units)

Figure 16. Global Wearable Injector Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026

Figure 17. Wearable Injector Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 18. Global Wearable Injector Devices Production Share by Manufacturers in 2015

Figure 19. The Top 10 and Top 5 Players Market Share by Wearable Injector Devices Revenue in 2019

Figure 20. Global Wearable Injector Devices Production Market Share by Region (2015-2020)

Figure 21. Wearable Injector Devices Production Growth Rate in North America (2015-2020) (K Units)

Figure 22. Wearable Injector Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)

Figure 23. Wearable Injector Devices Production Growth Rate in Europe (2015-2020) (K Units)

Figure 24. Wearable Injector Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)

Figure 25. Wearable Injector Devices Production Growth Rate in China (2015-2020) (K Units)

Figure 26. Wearable Injector Devices Revenue Growth Rate in China (2015-2020) (US$ Million)

Figure 27. Wearable Injector Devices Production Growth Rate in Japan (2015-2020) (K Units)

Figure 28. Wearable Injector Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)

Figure 29. Global Wearable Injector Devices Consumption Market Share by Regions 2015-2020

Figure 30. North America Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 31. North America Wearable Injector Devices Consumption Market Share by Application in 2019

Figure 32. North America Wearable Injector Devices Consumption Market Share by Countries in 2019

Figure 33. U.S. Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 34. Canada Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 35. Europe Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 36. Europe Wearable Injector Devices Consumption Market Share by Application in 2019

Figure 37. Europe Wearable Injector Devices Consumption Market Share by Countries in 2019

Figure 38. Germany Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 39. France Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 40. U.K. Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 41. Italy Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 42. Russia Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 43. Asia Pacific Wearable Injector Devices Consumption and Growth Rate (K Units)

Figure 44. Asia Pacific Wearable Injector Devices Consumption Market Share by Application in 2019

Figure 45. Asia Pacific Wearable Injector Devices Consumption Market Share by Regions in 2019

Figure 46. China Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 47. Japan Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 48. South Korea Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 49. India Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 50. Australia Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 51. Taiwan Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 52. Indonesia Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 53. Thailand Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 54. Malaysia Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 55. Philippines Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 56. Vietnam Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 57. Latin America Wearable Injector Devices Consumption and Growth Rate (K Units)

Figure 58. Latin America Wearable Injector Devices Consumption Market Share by Application in 2019

Figure 59. Latin America Wearable Injector Devices Consumption Market Share by Countries in 2019

Figure 60. Mexico Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 61. Brazil Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 62. Argentina Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 63. Middle East and Africa Wearable Injector Devices Consumption and Growth Rate (K Units)

Figure 64. Middle East and Africa Wearable Injector Devices Consumption Market Share by Application in 2019

Figure 65. Middle East and Africa Wearable Injector Devices Consumption Market Share by Countries in 2019

Figure 66. Turkey Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 67. Saudi Arabia Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 68. U.A.E Wearable Injector Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 69. Global Wearable Injector Devices Production Market Share by Type (2015-2020)

Figure 70. Global Wearable Injector Devices Production Market Share by Type in 2019

Figure 71. Global Wearable Injector Devices Revenue Market Share by Type (2015-2020)

Figure 72. Global Wearable Injector Devices Revenue Market Share by Type in 2019

Figure 73. Global Wearable Injector Devices Production Market Share Forecast by Type (2021-2026)

Figure 74. Global Wearable Injector Devices Revenue Market Share Forecast by Type (2021-2026)

Figure 75. Global Wearable Injector Devices Market Share by Price Range (2015-2020)

Figure 76. Global Wearable Injector Devices Consumption Market Share by Application (2015-2020)

Figure 77. Global Wearable Injector Devices Value (Consumption) Market Share by Application (2015-2020)

Figure 78. Global Wearable Injector Devices Consumption Market Share Forecast by Application (2021-2026)

Figure 79. SteadyMed Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 80. UNILIFE CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018

Figure 81. Sensile Medical AGInsulet Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 82. Enable Injections Total Revenue (US$ Million): 2019 Compared with 2018

Figure 83. Becton Total Revenue (US$ Million): 2019 Compared with 2018

Figure 84. West Pharmaceutical Services, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 85. Ypsomed Total Revenue (US$ Million): 2019 Compared with 2018

Figure 86. Amgen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 87. Buhler Motor GmbH Total Revenue (US$ Million): 2019 Compared with 2018

Figure 88. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018

Figure 89. Johnson & Johnson Services, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 90. CeQur SA. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 91. Global Wearable Injector Devices Revenue Forecast by Regions (2021-2026) (US$ Million)

Figure 92. Global Wearable Injector Devices Revenue Market Share Forecast by Regions ((2021-2026))

Figure 93. Global Wearable Injector Devices Production Forecast by Regions (2021-2026) (K Units)

Figure 94. North America Wearable Injector Devices Production Forecast (2021-2026) (K Units)

Figure 95. North America Wearable Injector Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 96. Europe Wearable Injector Devices Production Forecast (2021-2026) (K Units)

Figure 97. Europe Wearable Injector Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 98. China Wearable Injector Devices Production Forecast (2021-2026) (K Units)

Figure 99. China Wearable Injector Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 100. Japan Wearable Injector Devices Production Forecast (2021-2026) (K Units)

Figure 101. Japan Wearable Injector Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 102. Global Wearable Injector Devices Consumption Market Share Forecast by Region (2021-2026)

Figure 103. Wearable Injector Devices Value Chain

Figure 104. Channels of Distribution

Figure 105. Distributors Profiles

Figure 106. Porter's Five Forces Analysis

Figure 107. Bottom-up and Top-down Approaches for This Report

Figure 108. Data Triangulation

Figure 109. Key Executives Interviewed

SteadyMed Therapeutics, Inc.

UNILIFE CORPORATION

Sensile Medical AGInsulet Corporation

Enable Injections

Becton

West Pharmaceutical Services, Inc.

Ypsomed

Amgen

Buhler Motor GmbH

F. Hoffmann-La Roche Ltd

Johnson & Johnson Services, Inc.

CeQur SA.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3675

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase